MartinPCarrollMD
Oncology • Philadelphia, PAAssociate Professor, Medicine, Perelman School of Medicine
Are you Dr. Carroll?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
# 15
Philadelphia, PA 19104Phone+1 215-662-3914
Summary
- Dr. Martin Carroll, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1997
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
Geisel School of Medicine at DartmouthClass of 1988
Certifications & Licensure
PA State Medical License 1998 - 2024
Publications & Presentations
PubMed
- In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.Robert L Bowman, Andrew J Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R Waarts
Cancer Cell. 2024-11-11 - A line in shifting sand: Can we define and target TP53 mutated MDS?Sarah Skuli, Andrew Matthews, Martin Carroll, Catherine Lai
Seminars in Hematology. 2024-11-06 - A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley, Ryan M Morrow, Kevin A Janssen
The Journal of Clinical Investigation. 2024-05-07
Press Mentions
Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 6th, 2019- Heterogeneity of Human Bone Marrow and Blood Natural Killer Cells Defined by Single-Cell TranscriptomeSeptember 2nd, 2019
Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32August 7th, 2018
Grant Support
- Stem Cells, Differentiation And Therapeutic Resistance In AMLNational Cancer Institute2011–2012
- A Phase I/II Trial Of Eltrombopag In Elderly Acute Myeloid Leukemia PatientsNational Cancer Institute2011
- Core D: Xenotransplantation Mouse CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- The Role Of BCR/ABL In Regulating DNA RepairNational Cancer Institute2004–2008
- Mechanisms Of Transformation By TEL PdgfbrNational Cancer Institute1998–2001
- Mechanisms Of Transformation By TEL PdgfbrNational Cancer Institute1997–1998
